These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20001214)

  • 1. Novel discoveries in understanding the complexities of epilepsy and major depression.
    Dhir A
    Expert Opin Ther Targets; 2010 Jan; 14(1):109-15. PubMed ID: 20001214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The medical management of depression.
    Mann JJ
    N Engl J Med; 2005 Oct; 353(17):1819-34. PubMed ID: 16251538
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.
    Trivedi MH; Hollander E; Nutt D; Blier P
    J Clin Psychiatry; 2008 Feb; 69(2):246-58. PubMed ID: 18363453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual-action hypothesis: does pharmacology matter?
    Shelton RC
    J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence.
    Kanner AM
    Epilepsy Behav; 2016 Aug; 61():282-286. PubMed ID: 27236241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
    Ishigooka J
    Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?
    Hamid H; Kanner AM
    Epilepsy Behav; 2013 Mar; 26(3):261-5. PubMed ID: 23395350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.
    Millan MJ
    Pharmacol Ther; 2006 May; 110(2):135-370. PubMed ID: 16522330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Don't be afraid to treat depression in patients with epilepsy!
    Kondziella D; Asztely F
    Acta Neurol Scand; 2009 Feb; 119(2):75-80. PubMed ID: 18759799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure.
    Nutt D; Demyttenaere K; Janka Z; Aarre T; Bourin M; Canonico PL; Carrasco JL; Stahl S
    J Psychopharmacol; 2007 Jul; 21(5):461-71. PubMed ID: 17050654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant drug development: Focus on triple monoamine reuptake inhibition.
    Lane RM
    J Psychopharmacol; 2015 May; 29(5):526-44. PubMed ID: 25315829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levomilnacipran: a newly approved drug for treatment of major depressive disorder.
    Mago R; Mahajan R; Thase ME
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):137-45. PubMed ID: 24524592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physical recovery is part of remission].
    Krankenpfl J; 2004; 42(3-4):110. PubMed ID: 15311907
    [No Abstract]   [Full Text] [Related]  

  • 14. [Duloxetin effective in depression and pain: high remission rates obtained].
    MMW Fortschr Med; 2006 Jun; 148(23):63. PubMed ID: 16826744
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor.
    Nichols AI; Tourian KA; Tse SY; Paul J
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1565-74. PubMed ID: 21067460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.
    Bourin M; Chenu F; Prica C; Hascoët M
    Psychopharmacology (Berl); 2009 Sep; 206(1):97-107. PubMed ID: 19517098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
    Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA
    J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.